Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Blincyto in Children With CD19+ Precursor B-lineage ALL and MRD-Positivity Before and/or Following First Allogeneic HSCT

NCT04785547 is registered in ClinicalTrials.gov with Prof. Christina Peters as lead sponsor.

NCT NCT04785547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04785547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Blincyto in Children With CD19+ Precursor B-lineage ALL and MRD-Positivity Before and/or Following First Allogeneic HSCT
Lead sponsor
Prof. Christina Peters
Phase
Phase 2
Overall status
Terminated
Start date
December 17, 2020
Completion date
January 22, 2022
Enrollment
3 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

all, childhood, minimal residual disease